List view / Grid view
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
Researchers have tested samples of N. gonorrhoeae from patients with infections in the throat, urethra, cervix and rectum, they found that at very low amounts closthioamide was effective...
The Medical Research Council has formed partnerships with UCB and AstraZeneca, the deals will help speed translation of discovery research into potential therapies...
Prior to joining CRT-DL, Dr Ryder held positions in pharmaceutical and biotech companies for over 20 years ...
Evidence that the activation of a biological pathway necroptosis is closely linked with Alzheimer's...
Market intelligence suggests pharma is being forced to shift focus towards niche patient populations and orphan diseases ...
Takeda has launched a contract research and development company, AXCELEAD, at its Shonan Research Centre.
Cancer research at the University of Warwick has received a boost thanks to the former Lord Mayor of Coventry Cllr Lindsley Harvard.
Researchers at the University of Birmingham have identified inflammatory biomarkers which indicate whether the brain has suffered injury.
Dr Reda Lebcir from the University of Hertfordshire is part of an international team of researchers awarded a £2m grant from the ESRC (Economic and Social research Council).
Research reveals cathepsins as potential therapeutic targets in particulate-mediated inflammatory disease…
Elsevier has launched a new solution aimed at accelerating drug discovery through comprehensive prediction and assessment of drug-drug interactions (DDI).
Bio 2017 opens this week and Drug Target Review’s Niamh Marriott spoke with Richard Soll, Senior Vice President, Research Service Division, WuXi AppTec and Salvatore La Rosa, Vice President Research and Development, Children’s Tumor Foundation, to get their perspectives on one of the event’s most pressing trends. Both will be…
Numab Therapeutics announced a collaboration and option agreement with Kaken Pharmaceutical for the identification of a multispecific antibody candidate for development in inflammatory disease.
Companies to continue collaboration in discovery of next generation anti-malaria drugs...
A study by researchers at the University of Missouri School of Medicine found that the diabetes medication linagliptin can protect against stiffening of the left ventricle of the heart in overweight female mice. The finding may have implications for management of cardiovascular disease in humans.
